Published in Can J Ophthalmol on February 01, 2013
Pediatric open globe injury: A review of the literature. J Emerg Trauma Shock (2015) 0.81
Intraocular foreign bodies extracted by pars plana vitrectomy: clinical characteristics, management, outcomes and prognostic factors. BMC Ophthalmol (2015) 0.80
The sunflower cataract in Wilson's disease: pathognomonic sign or rare finding? Acta Neurol Belg (2015) 0.78
Role of B-scan ultrasonography in the localization of intraocular foreign bodies in the anterior segment: a report of three cases. BMC Ophthalmol (2015) 0.75
Intraocular foreign bodies. CMAJ (2016) 0.75
Intraoperative Macula Protection by Perfluorocarbon Liquid for the Metallic Intraocular Foreign Body Removal during 23-Gauge Vitrectomy. J Ophthalmol (2017) 0.75
Comparison of Regional vs. General Anesthesia for Surgical Repair of Open-Globe Injuries at a University Referral Center. Ophthalmol Retina (2017) 0.75
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol (2007) 8.12
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol (2009) 5.41
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina (2006) 3.98
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina (2006) 3.48
Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina (2014) 3.41
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina (2006) 3.29
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina (2006) 3.00
Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97
Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol (2013) 2.90
Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66
Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology (2012) 2.41
Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13
Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina (2014) 2.11
Ophthalmic fundus imaging: today and beyond. Am J Ophthalmol (2004) 2.03
Visual and anatomical outcomes of macular epiretinal membrane peeling after previous rhegmatogenous retinal detachment repair. Retina (2015) 1.98
Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol (2011) 1.92
Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol (2008) 1.92
Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol (2004) 1.91
Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86
Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol (2011) 1.83
Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol (2010) 1.82
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina (2008) 1.75
Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol (2004) 1.74
ENDOPHTHALMITIS CAUSED BY PSEUDOMONAS AERUGINOSA: Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes. Retina (2015) 1.58
Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina (2008) 1.57
Photoreceptor inner/outer segment defect imaging by spectral domain OCT and visual prognosis after macular hole surgery. Invest Ophthalmol Vis Sci (2009) 1.54
Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology (2008) 1.51
Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol (2009) 1.48
An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol (2012) 1.45
Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol (2003) 1.44
Reducing the risk of endophthalmitis following intravitreal injections. Retina (2007) 1.39
Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics. Retina (2010) 1.38
Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology (2003) 1.36
Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2010) 1.33
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol (2009) 1.33
Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes. Ophthalmology (2003) 1.29
Endophthalmitis caused by enterococcus faecalis: antibiotic selection and treatment outcomes. Ophthalmology (2003) 1.21
Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes. Retina (2011) 1.20
Update on retinal detachment surgery. Curr Opin Ophthalmol (2013) 1.19
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology (2002) 1.18
Anti-VEGF Treatment Strategies for Wet AMD. J Ophthalmol (2012) 1.17
Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol (2010) 1.14
Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol (2004) 1.12
Persistent outer retinal defect after successful macular hole repair. Am J Ophthalmol (2005) 1.12
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol (2003) 1.11
In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol (2006) 1.11
Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome. J Ophthalmic Inflamm Infect (2013) 1.09
Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration. Retina (2009) 1.09
Documentation by spectral domain OCT of spontaneous closure of idiopathic macular holes. Ophthalmic Surg Lasers Imaging (2007) 1.09
Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Can J Ophthalmol (2013) 1.08
Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol (2002) 1.08
Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery. Am J Ophthalmol (2003) 1.08
“Using spectral-domain optical coherence tomography imaging to identify the presence of retinal silicone oil emulsification after silicone oil tamponade.”. Retina (2014) 1.07
Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments. Ophthalmology (2003) 1.06
Primary retinal detachment: scleral buckle or pars plana vitrectomy? Curr Opin Ophthalmol (2006) 1.05
Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers (2002) 1.05
Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol (2013) 1.05
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina (2006) 1.05
Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina (2007) 1.04
"Floater scotoma" demonstrated on spectral-domain optical coherence tomography and caused by vitreous opacification. Ophthalmic Surg Lasers Imaging Retina (2013) 1.03
Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. Ophthalmic Surg Lasers Imaging Retina (2015) 1.03
Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion. Retina (2009) 1.02
Vision loss associated with the use and removal of intraocular silicone oil. Clin Ophthalmol (2008) 1.02
Endophthalmitis caused by Klebsiella species. Am J Ophthalmol (2004) 1.02
Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol (2005) 1.02
Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology (2002) 1.02
Spectral-Domain Optical Coherence Tomography Documentation of Transsynaptic Retinal Degeneration. Ophthalmic Surg Lasers Imaging Retina (2016) 1.01
Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments. Ophthalmology (2003) 1.00
Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes. J Ophthalmic Inflamm Infect (2013) 0.98
Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina (2014) 0.98
Fluocinolone acetonide implantable device for diabetic retinopathy. Curr Pharm Biotechnol (2011) 0.97
Scleral buckle infections: microbiological spectrum and antimicrobial susceptibility. J Ophthalmic Inflamm Infect (2013) 0.97
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging (2007) 0.97
Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. Retina (2008) 0.96
Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Ophthalmology (2013) 0.96
Spontaneous visual improvement following a large traumatic submacular hemorrhage. Ophthalmic Surg Lasers Imaging (2007) 0.96
Delayed-onset endophthalmitis following cataract surgery caused by Acremonium strictum. Ophthalmic Surg Lasers Imaging (2005) 0.96
Endogenous endophthalmitis caused by salmonella serotype B in an immunocompetent 12-year-old child. Arch Ophthalmol (2012) 0.96
Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result. Clin Ophthalmol (2011) 0.94
Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies. J Ophthalmol (2012) 0.94
Documentation of optic nerve pit with macular schisis-like cavity by spectral domain OCT. Ophthalmic Surg Lasers Imaging (2007) 0.94
Stenotrophomonas maltophilia endophthalmitis following cataract surgery: clinical and microbiological results. Clin Ophthalmol (2013) 0.94
Endophthalmitis after open globe injuries. Am J Ophthalmol (2009) 0.94
Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging (2003) 0.94
Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect (2013) 0.94
Aflibercept-related sterile inflammation. Ophthalmology (2013) 0.93
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology (2007) 0.93
Endophthalmitis caused by Bacillus species. Am J Ophthalmol (2008) 0.93
Multiple evanescent white dot syndromes. J Ophthalmic Inflamm Infect (2011) 0.93
Acute acquired toxoplasma retinitis may present similarly to unilateral acute idiopathic maculopathy. Am J Ophthalmol (2004) 0.92
Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain. Ophthalmic Surg Lasers Imaging (2011) 0.92
Clinical course of vitreomacular adhesion managed by initial observation. Retina (2014) 0.91
Endophthalmitis caused by Haemophilus influenzae. Ophthalmology (2004) 0.91